KARVEZIDE 300 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
KARVEZIDE 300 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Commercialized
Register Number
98085024IP
Prescription Type
Medicamento Sujeto A Prescripción Médica
Authorization Date
Sep 14, 2023
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number98085024IP
EMA Approved
Yes
Drug Classification
✗
Generic
No
✗
Orphan
No
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (2)
HIDROCLOROTIAZIDAActive
Quantity: 25 mg
Name: HIDROCLOROTIAZIDA
IRBESARTANActive
Quantity: 300 mg
Name: IRBESARTAN
ATC CLASSIFICATION (3)
C09D
C09DA
C09DA04